Anti-inflammatory effects of pentoxifylline: Importance in cardiac surgery;Antiinflammatorische effekte von pentoxifyllin: Bedeutung bei herzchirurgischen eingriffen

Anaesthesist

Volumn 58, Issue 11, 2009, Pages 1136-1143

  Groesdonk, H V ^a,b   Heringlake, M ^b   Heinze, H ^b  

^a SAARLAND UNIVERSITY   (Germany)

^b UNIVERSITY OF LÜBECK   (Germany)

Author keywords

Cardiopulmonary bypass; Cardiovascular surgery; Immunomodulation; Phosphodiesterase inhibitors

Indexed keywords

PENTOXIFYLLINE; PLACEBO;

ANTIINFLAMMATORY ACTIVITY; CARDIOPULMONARY BYPASS; CEREBROVASCULAR DISEASE; DRUG CLEARANCE; DRUG ELIMINATION; DRUG METABOLISM; ENZYME ACTIVITY; FLOW KINETICS; HEART SURGERY; HUMAN; INTERMITTENT CLAUDICATION; ISCHEMIA; REPERFUSION INJURY; REVIEW;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CARDIAC SURGICAL PROCEDURES; HUMANS; PENTOXIFYLLINE; PHOSPHODIESTERASE INHIBITORS; REPERFUSION INJURY; SEPSIS; VASODILATOR AGENTS;

EID: 72149108135     PISSN: 00032417     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00101-009-1626-9     Document Type: Review

References (62)

1. Akriviadis E, Botla R, Briggs W et al (2000) Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial. Gastroenterology 119:1637-1648
2. Argel MI, Vittone L, Grassi AO et al (1980) Effect of phosphodiesterase inhibitors on heart contractile behaviour, protein kinase activity and cyclic nucleotide levels. J Mol Cell Cardiol 12:939-954
3. Asimakopoulos G, Gourlay T (2003) A review of anti-inflammatory strategies in cardiac surgery. Perfusion 18 [Suppl 1]:7-12
4. Bahlmann L, Weber C, Heinrichs G et al (2006) The effect of pentoxifylline on cognitive dysfunction and mood state after open coronary revascularisation while using the heart-lung machine. Anaesthesiol Intensivmed 47:255-263
5. Barroso-Aranda J, Schmid-Schonbein GW (1990) Pentoxifylline pretreatment decreases the pool of circulating activated neutrophils, in-vivo adhesion to endothelium, and improves survival from hemorrhagic shock. Biorheology 27:401-418
6. Beermann B, Ings R, Mansby J et al (1985) Kinetics of intravenous and oral pentoxifylline in healthy subjects. Clin Pharmacol Ther 37:25-28
7. Bessler H, Gilgal R, Djaldetti M et al (1986) Effect of pentoxifylline on the phagocytic activity, cAMP levels, and superoxide anion production by monocytes and polymorphonuclear cells. J Leukoc Biol 40:747-754
8. Boldt J, Brosch C, Lehmann A et al (2001) Prophylactic use of pentoxifylline on inflammation in elderly cardiac surgery patients. Ann Thorac Surg 71:1524-1529
9. Boldt J, Brosch C, Piper SN et al (2001) Influence of prophylactic use of pentoxifylline on postoperative organ function in elderly cardiac surgery patients. Crit Care Med 29:952-958 (Pubitemid 32424344)
10. Cagli K, Ulas MM, Ozisik K et al (2005) The intraoperative effect of pentoxifylline on the inflammatory process and leukocytes in cardiac surgery patients undergoing cardiopulmonary bypass. Perfusion 20:45-51
11. Coe DA, Freischlag JA, Johnson D et al (1997) Pentoxifylline prevents endothelial damage due to ischemia and reperfusion injury. J Surg Res 67:21-25
12. Coimbra R, Melbostad H, Loomis W et al (2006) LPS-induced acute lung injury is attenuated by phosphodiesterase inhibition: effects on proinflammatory mediators, metalloproteinases, NF-kappaB, and ICAM-1 expression. J Trauma 60:115-125
13. Coimbra R, Melbostad H, Loomis W et al (2005) Phosphodiesterase inhibition decreases nuclear factor-kappaB activation and shifts the cytokine response toward anti-inflammatory activity in acute endotoxemia. J Trauma 59:575-582
14. Coimbra R, Porcides RD, Melbostad H et al (2005) Nonspecific phosphodiesterase inhibition attenuates liver injury in acute endotoxemia. Surg Infect 6:73-85
15. De Campos T, Deree J, Martins JO et al (2008) Pentoxifylline attenuates pulmonary inflammation and neutrophil activation in experimental acute pancreatitis. Pancreas 37:42-49
16. De Campos T, Deree J, Martins JO et al (2008) Pentoxifylline attenuates pulmonary inflammation and neutrophil activation in experimental acute pancreatitis. Pancreas 37:42-49
17. Faist E, Kim C (1998) Therapeutic immunomodulatory approaches for the control of systemic inflammatory response syndrome and the prevention of sepsis. New Horiz 6:S97-S102
18. Friedrich M, Sterry W, Klein A et al (2001) Addition of pentoxifylline could reduce the side effects of fumaric acid esters in the treatment of psoriasis. Acta Derm Venereol 81:429-430
19. Golbasi I, Akbas H, Ozdem S et al (2006) The effect of entoxifylline on haemolysis during cardiopulmonary bypass in open-heart surgery. Acta Cardiol 61:7-11
20. Groesdonk HV, Bauer A, Kreft B et al (2009) Urodilatin and pentoxifylline prevent the early onset of Escherichia coli-induced acute renal failure in a model of isolated perfused rat kidney. Kidney Blood Press Res 32:81-90
21. Heinze H, Rosemann C, Weber C et al (2007) A single prophylactic dose of pentoxifylline reduces high dependency unit time in cardiac surgery - a prospective randomized and controlled study. Eur J Cardiothorac Surg 32:83-89
22. Hemmer CJ, Hort G, Chiwakata CB et al (1997) Supportive pentoxifylline in falciparum malaria: no effect on tumor necrosis factor alpha levels or clinical outcome: a prospective, randomized, placebo-controlled study. Am J Trop Med Hyg 56:397-403
23. Hoffmann H, Markewitz A, Kreuzer E et al (1998) Pentoxifylline decreases the incidence of multiple organ failure in patients after major cardio-thoracic surgery. Shock 9:235-240
24. Iskesen I, Kurdal AT, Kahraman N et al (2009) Preoperative oral pentoxifylline for management of cytokine reactions in cardiac surgery. Heart Surg Forum 12:E100-E104
25. Iskesen I, Saribulbul O, Cerrahoglu M et al (2006) Pentoxifylline affects cytokine reaction in cardiopulmonary bypass. Heart Surg Forum 9:E883-E887
26. Kleinschmidt S, Bauer M, Grundmann U et al (1997) Effect of gamma-hydroxybutyric acid and pentoxifylline on kidney function parameters in coronary surgery interventions. Anaesthesiol Reanim 22:102-107
27. Koul BL, Nordhas O, Sonnenfeld T et al (1984) The effect of pentoxifylline on impaired red cell deformability following open-heart surgery. Scand J Thorac Cardiovasc Surg 18:129-131
28. Kowalski J, Kosmider M, Pasnik J et al (1999) Pentoxifylline decreases neutrophil respiratory bursts in patients with stable angina. Fundam Clin Pharmacol 13:237-242
29. Lauterbach R, Pawlik D, Kowalczyk D et al (1999) Effect of the immunomodulating agent, pentoxifylline, in the treatment of sepsis in prematurely delivered infants: a placebo-controlled, double-blind trial. Crit Care Med 27:807-814
30. Lauterbach R, Zembala M (1996) Pentoxifylline reduces plasma tumour necrosis factor-alpha concentration in premature infants with sepsis. Eur J Pediatr 155:404-409
31. McKinley BA, Butler BD (1999) Comparison of skeletal muscle PO2, PCO2, and pH with gastric tonometric P(CO2) and pH in hemorrhagic shock. Crit Care Med 27:1869-1877
32. Noel C, Hazzan M, Coppin MC et al (1997) A randomized controlled trial of pentoxifylline for the prevention of delayed graft function in cadaveric kidney graft. Clin Transplant 11:169-173
33. Otani S, Kuinose M, Murakami T et al (2008) Preoperative oral administration of pentoxifylline ameliorates respiratory index after cardiopulmonary bypass through decreased production of IL-6. Acta Med Okayama 62:69-74
34. Pereda J, Gomez-Cambronero L, Alberola A et al (2006) o-administration of pentoxifylline and thiopental causes death by acute pulmonary oedema in rats. Br J Pharmacol 149:450-455
35. Rieckmann P, Weber F, Gunther A et al (1996) Pentoxifylline, a phosphodiesterase inhibitor, induces immune deviation in patients with multiple sclerosis. J Neuroimmunol 64:193-200
36. Sakaguchi T, Hayashi S (1978) Pentoxifylline: pharmacology and clinical trials of pentoxifylline. Pharmacometrics 15:153-183
37. Sampaio EP, Moraes MO, Nery JA et al (1998) Pentoxifylline decreases in vivo and in vitro tumour necrosis factor-alpha (TNF-alpha) production in lepromatous leprosy patients with erythema nodosum leprosum (ENL). Clin Exp Immunol 111:300-308
38. Schade UF, Von Der Bosch J, Schonharting M (1989) Pentoxifylline increases survival of mice in endotoxic shock. Prog Clin Biol Res 301:223-227
39. Schreiber P, Schröppel M, Heidrich H (1983) Effects of naftidrofuryl, pentoxifylline and bencyclane on the renal blood flow and renal excretion of conscious dogs. Herz 15:195-201
40. Shaw SM, Shah MK, Williams SG et al (2009) Immunological mechanisms of pentoxifylline in chronic heart failure. Eur J Heart Fail 11:113-118
41. Silomon M, Pizanis A, Larsen R et al (1998) Pentoxifylline prevention of altered hepatocyte calcium regulation during hemorrhagic shock/resuscitation. Crit Care Med 26:494-500
42. Sliwa K, Skudicky D, Candy G et al (2002) The addition of pentoxifylline to conventional therapy improves outcome in patients with peripartum cardiomyopathy. Eur J Heart Fail 4:305-309
43. Sliwa K, Woodiwiss A, Candy G et al (2002) Effects of pentoxifylline on cytokine profiles and left ventricular performance in patients with decompensated congestive heart failure secondary to idiopathic dilated cardiomyopathy. Am J Cardiol 90:1118-1122
44. Sliwa K, Woodiwiss A, Kone VN et al (2004) Therapy of ischemic cardiomyopathy with the immunomodulating agent pentoxifylline: results of a randomized study. Circulation 109:750-755
45. Sliwa K, Woodiwiss A, Libhaber E et al (2004) C-reactive protein predicts response to pentoxifylline in patients with idiopathic dilated cardiomyopathy. Eur J Heart Fail 6:731-734
46. Staubach KH, Schroder J, Stuber F et al (1998) Effect of pentoxifylline in severe sepsis: results of a randomized, dou ble-blind, placebo-controlled study. Arch Surg 133:94-100
47. Trajkovic V, Badovinac V, Popadic D et al (1997) Cell-specific effects of pentoxifylline on nitric oxide production and inducible nitric oxide synthase mRNA expression. Immunology 92:402-406
48. Tsang GM, Allen S, Pagano D et al (1996) Pentoxifylline preloading reduces endothelial injury and permeability in cardiopulmonary bypass. ASAIO J 42:M429-M434
49. Turkoz R, Yorukoglu K, Akcay A et al (1996) The effect of pentoxifylline on the lung during cardiopulmonary bypass. Eur J Cardiothorac Surg 10:339-346
50. Ustunsoy H, Sivrikoz MC, Bakir K et al (2002) The inhibition of pro-inflammatory cytokines with pentoxifylline in the cardiopulmunary bypass lung. Respir Med 96:275-279
51. Ustunsoy H, Sivrikoz MC, Tarakcioglu M et al (2006) The effects of pentoxifylline on the myocardial inflammation and ischemia-reperfusion injury during cardiopulmonary bypass. J Card Surg 21:57-61
52. Van Leenen D, Van Der Poll T, Levi M et al (1993) Pentoxifylline attenuates neutrophil activation in experimental endotoxemia in chimpanzees. J Immunol 151:2318-2325
53. Vittone L, Chiappe LE, Argel MI et al (1980) The mechanical and biochemical effects of pentoxifylline on the perfused rat heart. Experientia 36:1088-1090
54. Wang P, Ba ZF, Morrison MH et al (1992) Mechanism of the beneficial effects of pentoxifylline on hepatocellular function after trauma hemorrhage and resuscitation. Surgery 112:451-457; discussion 457-458
55. Wang W, Tam WF, Hughes CC et al (1997) c-Rel is a target of pentoxifylline-mediated inhibition of T lymphocyte activation. Immunity 6:165-174
56. Wang W, Zolty E, Falk S et al (2006) Pentoxifylline protects against endotoxin-induced acute renal failure in mice. Am J Physiol Renal Physiol 291:F1090-F1095
57. Ward A, Clissold SP (1987) Pentoxifylline. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy. Drugs 34:50-97 (Pubitemid 17092322)
58. Watanabe H, Furukawa Y, Chiba S (1982) Cardiovascular effects of aminophylline and pentoxifylline on intact dogs and isolated dog atria. Jpn Heart J 23:235-243
59. Weber F, Polak T, Gunther A et al (1998) Synergistic immunomodulatory effects of interferon-beta1b and the phosphodiesterase inhibitor pentoxifylline in patients with relapsing-remitting multiple sclerosis. Ann Neurol 44:27-34
60. Wenisch C, Looareesuwan S, Wilairatana P et al (1998) Effect of pentoxifylline on cytokine patterns in the therapy of complicated Plasmodium falciparum malaria. Am J Trop Med Hyg 58:343-347
61. Yada-Langui MM, Coimbra R, Lancellotti C et al (2000) Hypertonic saline and pentoxifylline prevent lung injury and bacterial translocation after hemorrhagic shock. Shock 14:594-598
62. Zhang M, Xu YJ, Saini HK et al (2005) Pentoxifylline attenuates cardiac dysfunction and reduces TNF-alpha level in ischemic-reperfused heart. Am J Physiol Heart Circ Physiol 289:H832-H839